Multicenter Randomized Controlled Trial of Surveillance Versus Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia: The SURVENT Trial: Study Rationale, Methodology, Innovation, and Implications.
- DOI
- 10.1053/j.gastro.2022.05.051
- Published
- 2022 Sep
- Container
- Gastroenterology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1053/j.gastro.2022.05.051,
title = {Multicenter Randomized Controlled Trial of Surveillance Versus Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia: The SURVENT Trial: Study Rationale, Methodology, Innovation, and Implications.},
author = {Wani S and Souza RF and Durkalski VL and Serrano J and Hamilton F and Shaheen NJ and SURVENT Trial Consortium},
year = {2022},
journal = {Gastroenterology},
doi = {10.1053/j.gastro.2022.05.051},
url = {https://doi.org/10.1053/j.gastro.2022.05.051}
}RIS
TY - JOUR TI - Multicenter Randomized Controlled Trial of Surveillance Versus Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia: The SURVENT Trial: Study Rationale, Methodology, Innovation, and Implications. AU - Wani S AU - Souza RF AU - Durkalski VL AU - Serrano J AU - Hamilton F AU - Shaheen NJ AU - SURVENT Trial Consortium PY - 2022 JO - Gastroenterology DO - 10.1053/j.gastro.2022.05.051 UR - https://doi.org/10.1053/j.gastro.2022.05.051 ER -
APA
S, W., RF, S., VL, D., J, S., F, H., NJ, S., & Consortium, S. T. (2022). Multicenter Randomized Controlled Trial of Surveillance Versus Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia: The SURVENT Trial: Study Rationale, Methodology, Innovation, and Implications.. Gastroenterology. https://doi.org/10.1053/j.gastro.2022.05.051
Source records
- pubmed · retrieved 2026-09-26T20:50:40.668Z